Tilly’s Inc (TLYS) Announces $1.00 Dividend

Share on StockTwits

Tilly’s Inc (NYSE:TLYS) announced a dividend on Friday, February 1st, Fidelity reports. Stockholders of record on Friday, February 15th will be paid a dividend of 1.00 per share by the specialty retailer on Wednesday, February 27th. The ex-dividend date of this dividend is Thursday, February 14th.

Shares of TLYS traded down $0.01 during mid-day trading on Friday, hitting $12.52. 181,875 shares of the stock were exchanged, compared to its average volume of 324,419. The stock has a market capitalization of $369.09 million, a price-to-earnings ratio of 19.26, a price-to-earnings-growth ratio of 1.27 and a beta of 0.35. Tilly’s has a 52-week low of $10.19 and a 52-week high of $25.46.

Tilly’s (NYSE:TLYS) last issued its quarterly earnings data on Wednesday, November 28th. The specialty retailer reported $0.24 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.23 by $0.01. The business had revenue of $146.80 million for the quarter, compared to analysts’ expectations of $148.74 million. Tilly’s had a return on equity of 14.04% and a net margin of 4.06%. The company’s revenue for the quarter was down 3.9% on a year-over-year basis. During the same period in the prior year, the firm earned $0.31 EPS. As a group, analysts expect that Tilly’s will post 0.79 earnings per share for the current year.

In related news, insider Hezy Shaked sold 20,000 shares of the stock in a transaction on Thursday, December 20th. The stock was sold at an average price of $10.68, for a total transaction of $213,600.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 48.26% of the company’s stock.

Several research firms recently weighed in on TLYS. Zacks Investment Research upgraded Tilly’s from a “sell” rating to a “hold” rating in a report on Wednesday, January 30th. Pivotal Research upgraded Tilly’s from a “hold” rating to a “buy” rating and decreased their price target for the company from $17.00 to $14.00 in a report on Thursday, December 6th. B. Riley decreased their price target on Tilly’s from $26.00 to $25.00 and set a “buy” rating on the stock in a report on Wednesday, November 21st. ValuEngine upgraded Tilly’s from a “sell” rating to a “hold” rating in a report on Tuesday. Finally, Bank of America began coverage on Tilly’s in a report on Wednesday, October 24th. They set a “buy” rating and a $20.00 price target on the stock. Two investment analysts have rated the stock with a hold rating and five have given a buy rating to the stock. The company has an average rating of “Buy” and a consensus target price of $18.40.

TRADEMARK VIOLATION NOTICE: This story was reported by Ticker Report and is the sole property of of Ticker Report. If you are reading this story on another site, it was illegally stolen and reposted in violation of US & international copyright and trademark legislation. The original version of this story can be read at https://www.tickerreport.com/banking-finance/4138880/tillys-inc-tlys-announces-1-00-dividend.html.

Tilly’s Company Profile

Tilly's, Inc retails casual apparel, footwear, and accessories for young men and women, and boys and girls in the United States. Its apparel merchandise includes tops, outerwear, bottoms, and dresses; and accessories merchandise comprises backpacks, hats, sunglasses, headphones, handbags, watches, jewelry, and others.

See Also: What is the Consumer Price Index (CPI)?

Receive News & Ratings for Tilly's Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilly's and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Ontology Gas Price Up 148.3% This Week
Ontology Gas Price Up 148.3% This Week
Atmos 24 Hour Trading Volume Tops $0.00
Atmos 24 Hour Trading Volume Tops $0.00
InZinc Mining  Shares Up 28.6%
InZinc Mining Shares Up 28.6%
Cellular Biomedicine Group  Releases  Earnings Results
Cellular Biomedicine Group Releases Earnings Results
Cincinnati Financial Co.  Director Dirk J. Debbink Acquires 351 Shares
Cincinnati Financial Co. Director Dirk J. Debbink Acquires 351 Shares
Insider Selling: Paratek Pharmaceuticals Inc  Director Sells 3,375 Shares of Stock
Insider Selling: Paratek Pharmaceuticals Inc Director Sells 3,375 Shares of Stock


Leave a Reply

© 2006-2019 Ticker Report